The Mississippi Stroke Education Consortium: A state-based template to promote stroke awareness, prevention and emergency treatment

Neuroepidemiology

Volumn 19, Issue 1, 2000, Pages 1-12

  Gordon, David Lee ^a,b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Emergency medical services; Quality improvement; Stroke awareness; Stroke education; Stroke management; Stroke prevention

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

DRUG APPROVAL; EDUCATION PROGRAM; EMERGENCY; FIBRINOLYTIC THERAPY; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; MEDICAL SOCIETY; REVIEW; STROKE; UNITED STATES; VOLUNTEER;

EID: 0033986908     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026232     Document Type: Review

References (43)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-1587.
2. Kwiatkowski TG, Libman R, Frankel M, Tilley B, Morgenstern L, Lu M, Broderick J, Marier J, Brott T, the NINDS rt-PA Stroke Study Group: The NINDS rt-PA stroke study: Sustained benefit at one year. Stroke 1998;29:288.
3. Chiu D, Krieger D, Villar-Cordova C, Kasner SE, Morgenstern LB, Bratina PL, Yatsu FM, Grotta JC: Intravenous tissue plasminogen activator for acute ischemic stroke. Feasibility, safety, and efficacy in the first year of clinical practice. Stroke 1998;29:18-22.
4. Tanne D, Mansbach HH, Verra P, Binder JR, Karanja PN, Dayno J, Dulli D, Book D, Levine SR, and the rt-PA in Clinical Practice Stroke Survey Group: Intravenous rt-PA therapy for stroke in clinical practice: A multicenter evaluation of outcome. Stroke 1998;29:288.
5. Grond M, Rudolf J, Schmulling S, Stenzel C, Neveling M: Can the NINDS results be transferred into daily routine? Stroke 1998;29:288.
6. Karbalai H, Demchuk AM, Hoyte KM, Klein GM, Feasby TE, Buchan AM: Effectiveness of tissue-type plasminogen activator for acute ischemic stroke: Consequences of protocol violation. Stroke 1999;30: 248.
7. Lopez-Yunez AM, Bruno A, Zurru C, Williams LS, Biller J: Protocol violations in community-based rt-PA use are associated with symptomatic intracerebral hemorrhage. Stroke 1999;30:264.
8. Fagan SC, Morgenstern LB, Petitta A, Ward RE, Tilley BC, Marler JR, Levine SR, Broderick JP, Kwiatkowski TG, Frankel M, Brott TG, Walker MD, and the NINDS rt-PA Stroke Study Group: Cost-effectiveness of tissue plaminogen activator for acute ischemic stroke. Neurology 1998;50:883-890.
9. Oh PI, Nadareishvili ZG, Korman S, Tran C, Norris JW: Costeffectiveness of tPA therapy in acute ischemic stroke in Canada. Stroke 1999; 30:267.
10. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meiter D, Larrue V, Bluhmi E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P, for the Second European-Australasian Acute Stroke Study Investigators: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998;352:1245-1251.
11. Clark WM, Albers GW: The ATLANTIS rt-PA (Alteplase) acute stroke trial: Final results. Stroke 1999;30:234.
12. Tilley BC, Lyden PD, Brott TG, Lu M, Levine SR, Welch KMA, for the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. Arch Neurol 1997;54:1466-1474.
13. Azzimondi G, Bassein L, Fiorani L, Nonino F, Montaguti U, Celin D, Re G, D'Alessandro R: Variables associated with hospital arrival time after stroke. Effect of delay on the clinical efficiency of early treatment. Stroke 1997;28:537-542.
14. Smith MA, Doliszny KM, Shahar E, McGovern PG, Arnett DK, Luepker RV: Delayed hospital arrival for acute stroke: The Minnesota stroke survey. Ann Intern Med 1998;129: 190-196.
15. Zweifler RM, Brody ML, Graves GC, U TT, Drinkard R, Cunningham S, Rothrock JF: Intravenous tPA for acute ischemic stroke: Therapeutic yield of a stroke code system. Neurology 1998;50:501-503.
16. Wester P, Rådberg J, Lundgren B, Peltonen M, for the Seek-Medical-Attention-in-Time Study Group: Factors associated with delayed admission to hospital and in-hospital delays in acute stroke and TIA. A prospective, multicenter study. Stroke 1999;30:40-48.
17. Rosamond WD, Gorton RA, Hinn AR, Hohenhaus SM, Morris DL: Rapid response to stroke symptoms: The delay in accessing stroke healthcare (DASH) study. Acad Emerg Med 1998;5:45-51.
18. Alberts MJ, Perry A, Dawson DV, Bertels C: Effects of public and professional education on reducing the delay in presentation and referral of stroke patients. Stroke 1992;23: 352-356.
19. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group: A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. Stroke 1997;28:1530-1540.
20. Williams LS, Bruno A, Rouch D, Marriott DJ: Stroke patients' knowledge of stroke. Influence on time to presentation. Stroke 1997;28:912-915.
21. Dornan WA, Stroink AR, Kattner KA, Johns JD, Gupta KL, Pegg EW, Dick HJ, Hayden CJ: A public education program is associated with a dramatic decrease in hospital arrival time in patients with acute stroke. Stroke 1999;30:232.
22. Morris DL, Rosamond WD, Hamilton S, Madden K, Schultz C: Delay from emergency department arrival to diagnostic evaluation for stroke: The Genentech stroke presentation survey. Stroke 1999;30:266.
23. Rosamond WD, Morris DL, Cook S, Evenson K, Hinn A, Schmidt K, Vallee J, Cairns C, Crane M: The impact of emergency medical services on delays after onset of stroke symptoms. Stroke 1999;30:266.
24. Chaturvedi S, Bertasio B, Femino L: Emergency physician attitudes toward thrombolytic therapy in acute stroke. J Stroke Cerebrovasc Dis 1998;7:442-445.
25. Morgenstern LB, Villar-Cordova C, Barnholtz JS, Frankowski RF, Grotta JC: Neurologists' attitudes regarding rt-PA for acute ischemic stroke. Stroke 1998;29:303.
26. Goldstein LB, Hey LA, Laney R: North Carolina stroke prevention and treatment facilities survey. rtPA therapy for acute stroke. Stroke 1998;29:2069-2072.
27. Lichtman JH, Krumholz HM, Cerese J, Brass LM: Rates and predictors of antithrombotic therapy following ischemic stroke. Stroke 1999; 30:242.
28. Biller J, Love BB: Nihilism and stroke therapy. Stroke 1991;22: 1105-1107.
29. Gordon DL, Reynolds PS, Roach CA, Ibrahim J: Nurses should be trained before administering stroke screenings. Stroke 1999;30:253.
30. Kothari R, Sauerbeck L, Jauch E, Broderick J, Brott T, Khoury J, Liu T: Patients' awareness of stroke signs, symptoms, and risk factors. Stroke 1997;28:1871-1875.
31. Samsa GP, Cohen SJ, Goldstein LG, Bonito AJ, Duncan PW, Enarson C, DeFriese GH, Horner RD, Matchar DB: Knowledge of risk among patients at increased risk for stroke. Stroke 1997;28:916-921.
32. Pancioli AM, Broderick J, Kothari R, Brott T, Tuchfarber A, Miller R, Khoury J, Jauch E: Public perception of stroke warning signs and knowledge of potential risk factors. JAMA 1998;279:1288-1292.
33. Becker KJ, Fruin MS, Gooding TD: Community knowledge of stroke in King County, Washington. Stroke 1999;30:232.
34. Schneck MJ, Lukovits T, Meyers S, Ziegler DW, Motton CK, Fabbrini C: Public perceptives regarding the relative importance of stroke risk factors. Stroke 1999;30:253.
35. Goldstein LB, Gradison M: Stroke-related knowledge among patients with access to medical care in the Stroke Belt. Stroke 1999;30:253.
36. Reynolds PS, Gordon DL, Roach CA, Ibrahim J: Stroke screenings can successfully educate the public. Stroke 1999;30:253.
37. Chiu D, Lee J, Clay D, Katz LB: Public awareness of the symptoms, risk factors, and treatments of stroke. Stroke 1999;30:254.
38. Soumerai SB, McLaughlin TJ, Gurwitz JH, Guadagnoli E, Hauptman PJ, Borbas C, Morris N, McLaughlin B, Gao X, Willison DJ, Asinger R, Gobel F: Effect of local medical opinion leaders on quality of care for acute myocardial infarction. A randomized controlled trial. JAMA 1998;279:1358-1363.
39. Nilasena DS: A national strategy for improving stroke prevention and treatment for Medicare beneficiaries. Stroke 1999;30:241.
40. Gordon DL, Cobb AB, McIlwain JS, Keller C, Roach CA, Sanchez N, Guy B, Miller D, Moore B, Meydrech EF: Cooperative stroke management project by a peer review organization. J Stroke Cerebrovasc Dis 1996;6:45-53.
41. Gordon DL, Reynolds PS, Cobb AB, Mcllwain JS, Keller C, Murphy T, Miller D, Watson M, Horn T, Meydrech EF: A stroke quality improvement project can positively affect practice patterns. Neurology 1999;52(suppl 2):A68-A69.
42. Newell SD Jr, Englert J, Box-Taylor A, Davis KM, Koch KE: Clinical efficiency tools improve stroke management in a rural southern health system. Stroke 1999;29:1092-1098.
43. Gordon DL, Issenberg SB, LaCombe DM, Saks DL: Prehospital provider training in the management of acute stroke. Stroke 1999; 30:265.